Wednesday, October 30, 2024
HomeTagsPulse Biosciences

Pulse Biosciences

Pulse Biosciences, Inc. Announces Receipt of FDA Breakthrough Device Designation for CellFX® nsPFA Cardiac Surgery System for the Treatment of Atrial Fibrillation

Pulse Biosciences, Inc, a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation technology, announced that it has received the Breakthrough Device Designation...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics